VIRIDIAN THERAPEUTICS INC (VRDN)
US92790C1045 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.64M | 102.83M | 155.60M | 42.30M | 45.90M | |||
| Marketable Securities | 521.55M | 374.54M | 269.00M | 154.70M | 81.70M | |||
| Receivables | 102.00K | 102.00K | 100.00K | 500.00K | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 13.53M | 9.01M | 6.50M | 2.70M | 2.00M | |||
| Total Current Assets | 626.82M | 486.48M | 431.20M | 200.20M | 129.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.01M | 3.34M | 2.90M | 2.10M | 800.00K | |||
| Other Non-Current Assets | 555.00K | 604.00K | 1.00M | 1.50M | 900.00K | |||
| Total Non-Current Assets | 3.56M | 3.95M | 3.90M | 3.50M | 1.70M | |||
| TOTAL ASSETS | 630.38M | 490.42M | 435.10M | 203.70M | 131.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 23.16M | 24.11M | 18.80M | 11.00M | 9.70M | |||
| Accounts Payable | 2.68M | 2.24M | 14.20M | 2.30M | 700.00K | |||
| Other Current Liabilities | 288.00K | 288.00K | 300.00K | 300.00K | 300.00K | |||
| Total Current Liabilities | 26.13M | 26.64M | 33.30M | 13.60M | 10.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 20.33M | 20.20M | 4.60M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.40M | 1.56M | 2.00M | 2.40M | 500.00K | |||
| Total Non-Current Liabilities | 21.72M | 21.77M | 6.70M | 2.40M | 500.00K | |||
| TOTAL LIABILITIES | 47.85M | 48.40M | 40.00M | 16.00M | 11.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -774.45M | -725.91M | -488.20M | -358.30M | -278.90M | |||
| Additional Paid In Capital | 1.16B | 960.54M | 741.10M | 412.10M | 218.10M | |||
| Common Shares | 200.35M | 207.06M | 142.60M | 134.10M | 180.80M | |||
| Other Shareholders' Equity | -367.00K | 338.00K | -400.00K | -200.00K | 0.00 | |||
| Shares Outstanding | 63.80M | 53.99M | 41.30M | 23.90M | 4.20M | |||
| Tangible Book Value per Share | 6.00 | 4.36 | 6.12 | 2.25 | -14.48 | |||
| Total Shareholders' Equity | 582.53M | 442.02M | 395.10M | 187.70M | 120.00M | |||
| TOTAL LIABILITIES AND EQUITY | 630.38M | 490.42M | 435.10M | 203.70M | 131.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.05 | 0.01 | N/A | N/A | |||
| Current Ratio | 23.99 | 18.26 | 12.95 | 14.72 | 12.11 | |||
| Return On Assets (ROA) | -34.60% | -48.48% | -29.85% | -38.98% | -84.33% | |||
| Return On Equity (ROE) | -37.44% | -53.78% | -32.87% | -42.31% | -92.27% | |||
All data in USD